OmniAb, Inc. (OABI)
4.71
+0.38
(+8.78%)
USD |
NASDAQ |
Aug 24, 16:00
4.70
-0.01
(-0.21%)
Pre-Market: 08:08
OmniAb Debt to Equity Ratio : 0.0727 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0727 |
| March 31, 2026 | 0.0749 |
| December 31, 2025 | 0.0761 |
| September 30, 2025 | 0.0759 |
| June 30, 2025 | 0.0831 |
| March 31, 2025 | 0.0822 |
| December 31, 2024 | 0.0805 |
| September 30, 2024 | 0.0817 |
| June 30, 2024 | 0.0827 |
| March 31, 2024 | 0.0827 |
| December 31, 2023 | 0.0813 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0807 |
| June 30, 2023 | 0.0794 |
| March 31, 2023 | 0.0759 |
| December 31, 2022 | 0.0756 |
| September 30, 2022 | 0.0034 |
| June 30, 2022 | 0.0034 |
| March 31, 2022 | 0.0383 |
| December 31, 2021 | 0.0591 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 11.67 |
| March 31, 2021 | 3.238 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IQVIA Holdings, Inc. | 2.632 |
| Champions Oncology, Inc. | 1.167 |
| Medpace Holdings, Inc. | 0.3322 |
| Charles River Laboratories International, Inc. | 1.069 |
| Avantor, Inc. | 0.6568 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 290.26M |
| Total Liabilities (Quarterly) | 29.98M |
| Shareholders Equity (Quarterly) | 260.27M |
| Current Ratio | 4.798 |
| Net Debt Paydown Yield | 0.20% |